
Broker’s call: Aurobindo Pharma (Buy)
Target: ₹1,360 CMP: ₹1,206 Aurobindo Pharma (ARBP) is actively investing across multiple high-potential segments to drive sustained growth over the next 3-5 years. The company’s Penicillin G (PEN-G) project is scaling up meaningfully, effectively curbing operational losses, and is expected to contribute materially to profitability in FY26 and FY27. In the US generics market, ARBP continues...
Read more